Literature DB >> 8421714

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.

A B Kulkarni1, C G Huh, D Becker, A Geiser, M Lyght, K C Flanders, A B Roberts, M B Sporn, J M Ward, S Karlsson.   

Abstract

To delineate specific developmental roles of transforming growth factor beta 1 (TGF-beta 1) we have disrupted its cognate gene in mouse embryonic stem cells by homologous recombination to generate TGF-beta 1 null mice. These mice do not produce detectable amounts of either TGF-beta 1 RNA or protein. After normal growth for the first 2 weeks they develop a rapid wasting syndrome and die by 3-4 weeks of age. Pathological examination revealed an excessive inflammatory response with massive infiltration of lymphocytes and macrophages in many organs, but primarily in heart and lungs. Many lesions resembled those found in autoimmune disorders, graft-vs.-host disease, or certain viral diseases. This phenotype suggests a prominent role for TGF-beta 1 in homeostatic regulation of immune cell proliferation and extravasation into tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421714      PMCID: PMC45747          DOI: 10.1073/pnas.90.2.770

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

2.  Histopathologic sequence of events in adult mice undergoing lethal graft-versus-host reaction developed across H-2 and/or non-H-2 histocompatibility barriers.

Authors:  H Rappaport; A Khalil; O Halle-Pannenko; L Pritchard; D Dantchev; G Mathé
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

3.  Mononuclear-cell pulmonary vasculitis in NZB/W mice. I. Histopathologic evaluation of spontaneously occurring pulmonary infiltrates.

Authors:  C Staszak; R J Harbeck
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

4.  Developmental expression of PDGF, TGF-alpha, and TGF-beta genes in preimplantation mouse embryos.

Authors:  D A Rappolee; C A Brenner; R Schultz; D Mark; Z Werb
Journal:  Science       Date:  1988-09-30       Impact factor: 47.728

5.  Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.

Authors:  A Miller; O Lider; A B Roberts; M B Sporn; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

6.  Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis.

Authors:  M K Racke; B Cannella; P Albert; M Sporn; C S Raine; D E McFarlin
Journal:  Int Immunol       Date:  1992-05       Impact factor: 4.823

7.  Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences.

Authors:  L M Wakefield; D M Smith; K C Flanders; M B Sporn
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

8.  Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.

Authors:  M M Shull; I Ormsby; A B Kier; S Pawlowski; R J Diebold; M Yin; R Allen; C Sidman; G Proetzel; D Calvin
Journal:  Nature       Date:  1992-10-22       Impact factor: 49.962

9.  Experimental autoimmune type of vasculitis resulting from activation of mouse lymphocytes to cultured endothelium.

Authors:  M N Hart; K L Sadewasser; P A Cancilla; L E DeBault
Journal:  Lab Invest       Date:  1983-04       Impact factor: 5.662

Review 10.  Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.

Authors:  S M Wahl
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

View more
  559 in total

1.  Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters.

Authors:  Q Wang; Y Wang; D M Hyde; P J Gotwals; V E Koteliansky; S T Ryan; S N Giri
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Tumour necrosis factor in mouse models of chronic intestinal inflammation.

Authors:  Christoph Mueller
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

3.  Decreased levels of miR-28-5p and miR-361-3p and increased levels of insulin-like growth factor 1 mRNA in mononuclear cells from patients with hereditary hemorrhagic telangiectasia 1.

Authors:  Anthony Cannavicci; Qiuwang Zhang; Si-Cheng Dai; Marie E Faughnan; Michael J B Kutryk
Journal:  Can J Physiol Pharmacol       Date:  2018-12-04       Impact factor: 2.273

4.  A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis.

Authors:  R Hernández-Pando; H Orozco-Esteves; H A Maldonado; D Aguilar-León; M M Vilchis-Landeros; D A Mata-Espinosa; V Mendoza; F López-Casillas
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

Review 5.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

6.  The Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells.

Authors:  Song Guo Zheng
Journal:  Int J Clin Exp Med       Date:  2008-06-10

7.  TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes.

Authors:  Ramireddy Bommireddy; Ilona Ormsby; Moying Yin; Gregory P Boivin; George F Babcock; Thomas Doetschman
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

8.  CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis.

Authors:  David Sancho; Manuel Gómez; Fernando Viedma; Enric Esplugues; Mónica Gordón-Alonso; María Angeles García-López; Hortensia de la Fuente; Carlos Martínez-A; Pilar Lauzurica; Francisco Sánchez-Madrid
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

9.  Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.

Authors:  A B Glick; A B Kulkarni; T Tennenbaum; H Hennings; K C Flanders; M O'Reilly; M B Sporn; S Karlsson; S H Yuspa
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

10.  Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice.

Authors:  K Sellheyer; J R Bickenbach; J A Rothnagel; D Bundman; M A Longley; T Krieg; N S Roche; A B Roberts; D R Roop
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.